- Nationality
- 🇸🇪 Sweden
- Affiliation
- Dept. of Laboratory Medicine, Karolinska Institutet, Sweden
- Field of study
- Health Professions and Related Clinical Sciences
- Residencies at STIAS
- 2021 2nd Semester 2017 2nd Semester
Projects
-
Review on the use of BTK inhibitors
The beauty of BTK inhibitors is that they impair tumor development by blocking normal, unmutated BTK, causing many lymphoid tumors to be sensitive, as we have reviewed. -
Systematic generation of an update of the ongoing studies on the new BTK inhibitors
BTK is a cytoplasmic protein-tyrosine kinase, whose corresponding gene was isolated in the early 1990s.
Related to this person
publication
Estimating the number of diseases – the concept of rare, ultra-rare, and hyper-rare
Smith, C. I. Edvard, Peter Bergman and Daniel W. Hagey. 2022. Estimating the number of diseases – the concept of rare, ultra-rare, and hyper-rare. iScience...
public lecture / seminar
The complex interaction of virus and body - Fellows' seminar by Edvard Smith
The main way for the immune system to identify viruses is through a specialised set of proteins, which display parts of the virus on the surface of the infected cell.
publication
Therapeutic Oligonucleotides: State of the Art
Smith, C.I. Edvard and Rula Zain. 2019. Therapeutic Oligonucleotides: State of the Art. Annual Review of Pharmacology and Toxicology, 59(1), 605–630. https...